$1.63
0.0050.31%
Last update: Nov 13, 10:26 AM
Alaunos Therapeutics Inc
TCRTNASDAQ
Alaunos Therapeutics fell 43.2% from $2.85 to $1.62, behind the S&P 500's +12.7%. Its worst day was Oct 14 (−31.7%), and its low came Oct 6 at $0.74.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.55 was reported on $0.00 revenue.
+8.4% · S&P 500 −0.9%
Alaunos Therapeutics closed at its highest level of the year, 53.0% above where the year started.
Story events cover the past 12 months · Times ET
+3.6% · S&P 500 −0.3%
EPS of $-0.36 was reported on $3,000.00 revenue.
+3.1% · S&P 500 +0.8%
EPS of $-0.06 was reported on $0.00 revenue.
+4.5% · S&P 500 −0.1%
EPS of $-0.41 was reported on $0.00 revenue.
−1.0% · S&P 500 −0.5%
Alaunos Therapeutics closed at its lowest level of the year, 73.9% below where the year started.
−6.4% · S&P 500 +0.5%
Where it ended: a close of $1.62 on Nov 12, 2026. Up next: Q3 2026 earnings on Nov 24, 2026.
Nothing in the past 12 months.
All TCRT analyst actionsNothing in the past 12 months.
All TCRT dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TCRT and SPY from Benzinga historical bars. Not investment advice.
